Fasudil
Showing 1 - 19 of 19
Idiopathic Parkinson´s Disease Trial in Munich (Fasudil HCl, Placebo)
Not yet recruiting
- Idiopathic Parkinson´s Disease
- Fasudil hydrochloride
- Placebo
-
Munich, GermanyTechnische Universität München, Klinikum rechts der Isar, Klinik
Jun 27, 2023
Dementia Trial in Australia, United States (Oral Fasudil 90 mg/day, Oral Fasudil 180 mg/day, Oral Placebo)
Completed
- Dementia
- Oral Fasudil 90 mg/day
- +2 more
-
Stamford, Connecticut
- +10 more
Jul 7, 2022
Progressive Supranuclear Palsy, Corticobasal Syndrome Trial in San Francisco (Fasudil)
Active, not recruiting
- Progressive Supranuclear Palsy
- Corticobasal Syndrome
- Fasudil
-
San Francisco, CaliforniaUniversity of California Weill Institute for Neurosciences
May 31, 2022
Amyotrophic Lateral Sclerosis Trial in France, Germany, Switzerland (Fasudil, Placebo)
Active, not recruiting
- Amyotrophic Lateral Sclerosis
- Fasudil
- Placebo
-
Marseille, France
- +14 more
Jun 2, 2022
Amyotrophic Lateral Sclerosis Trial in Australia, United States (Fasudil (WP-0512))
Recruiting
- Amyotrophic Lateral Sclerosis
- Fasudil (WP-0512)
-
Phoenix, Arizona
- +11 more
Oct 28, 2022
Retinopathy of Prematurity Trial in Tehran (Fasudil eye drops (concentration 0.5 percent), receive artificial tears drop)
Unknown status
- Retinopathy of Prematurity
- Fasudil eye drops (concentration 0.5 percent)
- receive artificial tears drop
-
Tehran, Iran, Islamic Republic ofOphthalmic Research Center
Dec 5, 2019
Cardiovascular Diseases Trial in Fort Collins (Fasudil Hydrochloride, Saline)
Completed
- Cardiovascular Diseases
- Fasudil Hydrochloride
- Saline
-
Fort Collins, ColoradoColorado State University, Dept. of Health and Exercise Science
Feb 23, 2020
GVHD Trial in Hackensack (Telmisartan)
Active, not recruiting
- GVHD
-
Hackensack, New JerseyHackensack University Medical Center
Sep 2, 2022
Rhegmatogenous Retinal Detachment, Proliferative Vitreoretinopathy Trial in Philadelphia (Netarsudil 0.02% Ophthalmic Solution
Not yet recruiting
- Rhegmatogenous Retinal Detachment
- Proliferative Vitreoretinopathy
- Netarsudil 0.02% Ophthalmic Solution [RHOPRESSA]
- Glycerin 0.2%/Hypromellose 0.2%/Peg 1%/Soln,Oph,Ud
-
Philadelphia, PennsylvaniaWills Eye Physicians - Mid Atlantic Retina
Dec 13, 2022
ST Segment Elevation Myocardial Infarction Trial (Fasudil Hydrochloride, Placebo saline)
Not yet recruiting
- ST Segment Elevation Myocardial Infarction
- Fasudil Hydrochloride
- Placebo saline
- (no location specified)
Nov 23, 2018
Subarachnoid Hemorrhage, Brain Ischemia, Subarachnoid Hemorrhage, Aneurysmal Trial in Mexico City (Dapsone, Aluminum Hydroxide
Completed
- Subarachnoid Hemorrhage
- +5 more
- Dapsone
- Aluminum Hydroxide Gel
-
Mexico City, MexicoEl Instituto Nacional de Neurologia y Neurocirugia Manuel Velasc
Nov 10, 2021
Retinal Vein Occlusion Trial in Tehran (injection bevacizumab, injection Combined Bevacizumab and Fasudil)
Unknown status
- Retinal Vein Occlusion
- injection bevacizumab
- injection Combined Bevacizumab and Fasudil
-
Tehran, Iran, Islamic Republic ofOphthalmic Research Center
Jan 4, 2018
Diabetic Macular Edema Trial in Tehran (Intravitreal injection of bevacizumab (Avastin), Intravitreal injection of fasudil and
Completed
- Diabetic Macular Edema
- Intravitreal injection of bevacizumab (Avastin)
- Intravitreal injection of fasudil and bevacizumab (Avastin)
-
Tehran, Iran, Islamic Republic of(unnamed)
May 10, 2017
Raynaud's Phenomenon Isolated Primary, Raynaud's Phenomenon (Secondary), Healthy Trial in Grenoble (Biopsy)
Completed
- Raynaud's Phenomenon Isolated Primary
- +2 more
- Biopsy
-
Grenoble, Isère, FranceCHU of Grenoble Alpes
Apr 8, 2020
Carotid Stenosis Trial in Boston (Fasudil Hydrochloride, Placebo Oral Tablet)
Terminated
- Carotid Stenosis
- Fasudil Hydrochloride
- Placebo Oral Tablet
-
Boston, MassachusettsBrigham and Women's Hospital
Feb 10, 2017
Raynaud, Scleroderma Trial in Baltimore (Fasudil)
Completed
- Raynaud
- Scleroderma
- Fasudil
-
Baltimore, MarylandJohns Hopkins University
Nov 3, 2014
Amyotrophic Lateral Sclerosis Trial in Beijing (Fasudil)
Unknown status
- Amyotrophic Lateral Sclerosis
- Fasudil
-
Beijing, ChinaPeking University Third Hospital
Sep 5, 2013
Heart Failure Trial in Tainan (Enalapril)
Unknown status
- Heart Failure
-
Tainan, TaiwanNational Cheng Kung University Hospital
Feb 23, 2010
Atherosclerosis, Hypercholesterolemia Trial in Boston (fasudil)
Completed
- Atherosclerosis
- Hypercholesterolemia
- fasudil
-
Boston, MassachusettsBrigham and Women's Hospital
Sep 26, 2008